NeuroMetrix, Inc. Common Stock
NURO
NURO was delisted on the 1st of May, 2025.
13 hedge funds and large institutions have $340K invested in NeuroMetrix, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 5 closing their positions.
50% more capital invested
Capital invested by funds: $227K → $340K (+$113K)
33% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 3
0% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 5
7% less funds holding
Funds holding: 14 → 13 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Cerity Partners
New York
|
+$126K |
| 2 |
Renaissance Technologies
New York
|
+$82.7K |
| 3 |
VF
Virtu Financial
New York
|
+$50.9K |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
+$26.4K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
-$46K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$20K |
| 3 |
State Street
Boston,
Massachusetts
|
-$12.9K |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$7.92K |
| 5 |
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
|
-$287 |
NURO Hedge Fund Activity: Q4 2023 in Review
13 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in NeuroMetrix, Inc. Common Stock (NURO) for Q4 2023, worth a combined $340K — up 50% from $227K a quarter earlier.
Fund positioning in NURO was balanced in Q4 2023: 5 funds opened new positions, 5 closed out, 4 added to existing stakes and 3 trimmed.
The largest buyer was Cerity Partners, opening a new position worth an estimated $126K. The largest seller was Geode Capital Management, exiting entirely with an estimated $46K sold.
- 13 institutional investors held NeuroMetrix, Inc. Common Stock (NURO) as of Q4 2023, down from 14 in Q3 2023.
- Funds reported $340K of NeuroMetrix, Inc. Common Stock stock for Q4 2023, up 50% quarter-over-quarter.
- 5 funds opened new NeuroMetrix, Inc. Common Stock positions in Q4 2023 and 5 closed out, a net change of 0 holders.
- The largest NeuroMetrix, Inc. Common Stock buyer in Q4 2023 was Cerity Partners, an estimated $126K added.
- The largest NeuroMetrix, Inc. Common Stock seller in Q4 2023 was Geode Capital Management, an estimated $46K sold.
Based on aggregated 13F filings for Q4 2023.